Atorvastatin improves disease activity of nonalcoholic steatohepatitis partly through its tumour necrosis factor-α-lowering propertyHideyuki Hyogo, Kazuaki Chayama, Tomokazu Ishitobi et al.|Digestive and Liver Disease|2012Cited by 55
Increased insulinogenic index is an independent determinant of nonalcoholic fatty liver disease activity score in patients with normal glucose toleranceHideyuki Hyogo, Kazuaki Chayama, Tomokazu Ishitobi et al.|Digestive and Liver Disease|2012Cited by 9
Serum levels of pigment epithelium-derived factor (PEDF) are independently associated with procollagen III N-terminal peptide levels in patients with nonalcoholic fatty liver diseaseHideyuki Hyogo, Kazuaki Chayama, Sho‐ichi Yamagishi et al.|Clinical Biochemistry|2012Cited by 5
Serum asymmetric dimethylarginine levels are independently associated with procollagen III N-terminal peptide in nonalcoholic fatty liver disease patientsHideyuki Hyogo, Kazuaki Chayama, Sho‐ichi Yamagishi et al.|Clinical and Experimental Medicine|2012Cited by 3
sRAGE is associated with low waist circumference and Hb levels in NAFLDHideyuki Hyogo, Kazuaki Chayama, Takashi Nakahara et al.|Open Medicine|2013Cited by 1